Status and phase
Conditions
Treatments
About
Volunteer participants are evaluated for eligibility during a Screening Visit; those meeting study inclusion/exclusion criteria are scheduled for 2 treatment visits. At each treatment visit, 1 of the 2 study treatments is self-administered to both eyes. Afterwards, efficacy and safety assessments are performed over a 3-hour period.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Primary Inclusion Criteria:
Primary Exclusion Criteria:
Primary purpose
Allocation
Interventional model
Masking
145 participants in 2 patient groups, including a placebo group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal